Bone Marrow Transplant Clinical Trials

Clinical trials related to Bone Marrow Transplant Procedure

Establishment of a Novel Flow Cytometric Diagnostic Assay to Effectively Evaluate Immune Reconstitution After Hematopoietic Stem Cell Transplantation for Acute Lymphoblastic Leukemia

Status: Recruiting
Location: See all (3) locations...
Study Type: Observational
SUMMARY

Primary Objective To assess immune reconstitution during the first 18 months following hematopoietic stem cell transplantation (HSCT) for acute lymphoblastic leukemia (ALL), with a particular focus on the T-cell compartment (thymic regeneration and surrogate markers of cytotoxic function), using a dedicated panel developed within the EuroFlow consortium. Secondary Objectives To assess the impact of donor and recipient characteristics, graft-versus-host disease (GvHD) prophylaxis, and conditioning regimen on post-transplant immune reconstitution. To evaluate the correlation between immune reconstitution and the development of complications using unsupervised analysis.

Eligibility
Participation Requirements
Sex: All
Healthy Volunteers: f
View:

• Patients who undergo first HSCT for ALL

• Signing of informed consent by the patient (age\>18) or by parent/legal guardian (age \<18)

Locations
Other Locations
Austria
Saint Anna Kinderspital
RECRUITING
Vienna
Italy
Fondazione IRCCS San Gerardo dei Tintori
RECRUITING
Monza
Azienda Ospedaliera Università Padova
RECRUITING
Padova
Time Frame
Start Date: 2025-02-13
Estimated Completion Date: 2028-06
Participants
Target number of participants: 150
Sponsors
Leads: Fondazione Matilde Tettamanti Menotti De Marchi Onlus

This content was sourced from clinicaltrials.gov

Similar Clinical Trials